NasdaqGM:VCELBiotechs
Assessing Vericel (VCEL) Valuation After BARDA Awards Up To US$197 Million NexoBrid Contract
BARDA Contract Puts NexoBrid Partnership in Focus for Vericel (VCEL)
Vericel (VCEL), the exclusive distributor of NexoBrid in North America, is back on investor radar after a ten-year BARDA contract valued at up to US$197 million, tied to NexoBrid procurement and development.
See our latest analysis for Vericel.
The BARDA news lands after a mixed run for Vericel, with a 30 day share price return of 2.49% contrasting with a 90 day share price return decline of 12.6% and a 1 year total...